Is Ticagrelor the Antiplatelet Therapy Panacea?

von Beitelshees, Amber L.
Veröffentlicht 2010

Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management

von Beitelshees, Amber L., Zineh, Issam
Veröffentlicht in Heart Fail Rev (2008)

Evolving research and stakeholder perspectives on pharmacogenomics

von Beitelshees, Amber L., Veenstra, David L.
Veröffentlicht 2011

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

von Beitelshees, Amber L, Voora, Deepak, Lewis, Joshua P
Veröffentlicht in Pharmgenomics Pers Med (2015)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research

von Beitelshees, Amber L., Leslie, Bruce R., Taylor, Simeon I.
Veröffentlicht in Diabetes (2019)

Pharmacological treatment of hyperglycemia in type 2 diabetes

von Taylor, Simeon I., Yazdi, Zhinous Shahidzadeh, Beitelshees, Amber L.
Veröffentlicht in J Clin Invest (2021)

Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel

von Reese, Emily S., Mullins, C. Daniel, Beitelshees, Amber L., Onukwugha, Eberechukwu
Veröffentlicht 2012

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes

von Zineh, Issam, Beitelshees, Amber L., Silverstein, Janet H., Haller, Michael J.
Veröffentlicht 2009

SGLT2 Inhibitors as Adjunctive Therapy for Type 1 Diabetes: Balancing Benefits versus Risks

von Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I., Beitelshees, Amber L.
Veröffentlicht in Lancet Diabetes Endocrinol (2019)

Single nucleotide polymorphism discovery and haplotype analysis of Ca(2+)-dependent K(+) channel beta-1 subunit

von Gong, Yan, Beitelshees, Amber L., Wessel, Jennifer, Langaee, Taimour Y., Schork, Nicholas J., Johnson, Julie A.
Veröffentlicht 2007

CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults

von Beitelshees, Amber L, Aquilante, Christina L, Allayee, Hooman, Langaee, Taimour Y, Welder, Gregory J, Schofield, Richard S, Zineh, Issam
Veröffentlicht 2012

Using Workflow Modeling to Identify Areas to Improve Genetic Test Processes in the University of Maryland Translational Pharmacogenomics Project

von Cutting, Elizabeth M., Overby, Casey L., Banchero, Meghan, Pollin, Toni, Kelemen, Mark, Shuldiner, Alan R., Beitelshees, Amber L.
Veröffentlicht in AMIA Annu Symp Proc (2015)

Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins

von Zineh, Issam, Beitelshees, Amber L., Welder, Gregory J., Hou, Wei, Chegini, Nasser, Wu, Jun, Cresci, Sharon, Province, Michael A., Spertus, John A.
Veröffentlicht 2008

Comparison of Office, Ambulatory, and Home Blood Pressure Antihypertensive Response to Atenolol and Hydrochlorthiazide

von Beitelshees, Amber L., Gong, Yan, Bailey, Kent R., Turner, Stephen T., Chapman, Arlene B., Schwartz, Gary L., Gums, John G., Boerwinkle, Eric, Johnson, Julie A.
Veröffentlicht 2009

Adrenergic-pathway Gene Variants Influence β-Blocker-related Outcomes after Acute Coronary Syndrome in a Race-specific Manner

von Cresci, Sharon, Dorn, Gerald W., Jones, Philip G., Beitelshees, Amber L., Li, Allie Y., Lenzini, Petra A., Province, Michael A., Spertus, John A., Lanfear, David E.
Veröffentlicht 2012

A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes

von Cresci, Sharon, Huss, Janice M., Beitelshees, Amber L., Jones, Philip G., Minton, Matt R., Dorn, Gerald W., Kelly, Daniel P., Spertus, John A., McLeod, Howard L.
Veröffentlicht 2010

Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension

von Turner, Stephen T., Schwartz, Gary L., Chapman, Arlene B., Beitelshees, Amber L., Gums, John G., Cooper-DeHoff, Rhonda M., Boerwinkle, Eric, Johnson, Julie A., Bailey, Kent R.
Veröffentlicht 2010

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response

von Turner, Stephen T, Schwartz, Gary L, Chapman, Arlene B, Beitelshees, Amber L, Gums, John G, Cooper-DeHoff, Rhonda M, Boerwinkle, Eric, Johnson, Julie A, Bailey, Kent R
Veröffentlicht 2012

Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide

von Del-Aguila, Jorge L., Cooper-DeHoff, Rhonda M., Chapman, Arlene B., Gums, John G., Beitelshees, Amber L., Bailey, Kent, Turner, Stephen T., Johnson, Julie A., Boerwinkle, Eric
Veröffentlicht in Pharmacogenomics J (2014)

Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and Atenolol

von Smith, Steven M., Gong, Yan, Turner, Stephen T., Cooper-DeHoff, Rhonda M., Beitelshees, Amber L., Chapman, Arlene B., Boerwinkle, Eric, Bailey, Kent, Johnson, Julie A., Gums, John G.
Veröffentlicht 2011